68Ga-PSMA has high diagnostic accuracy in the initial staging and biochemical recurrence evaluation in patients diagnosed with prostate cancer.5,6 It is also used in the context of PSMA radioligand theranostics, for lesions’ evaluation and patient selection with a good predictive value.7 This evidence concerns the gene FOLH1 and prostate carcinoma.